Inventor · disambiguated record
Hemanta Baruah
Also filed as: BARUAH HEMANTA
14 granted patents·7 pending applications·17 citations·filing 2007–2025
87Inventor score
Files withBlack Belt Therapeutics Ltd8DRAGONFLY THERAPEUTICS INC5INNOVENT BIOLOGICS SUZHOU CO LTD3ADIMAB LLC2TING ALICE Y2
Top patents by PatentIndex Score
21 records- 0185US12157771B2Proteins binding NKG2D, CD16 and CLEC12ADRAGONFLY THERAPEUTICS INC·Filed 2021·Granted Dec 3, 2024·1 cites·21 claims
- 0285US10316089B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2016·Granted Jun 11, 2019·7 cites·31 claims
- 0380US8137925B2Methods and compositions for protein labeling using lipoic acid ligasesTING ALICE Y·Filed 2007·Granted Mar 20, 2012·5 cites·20 claims
- 0476US11236173B2CD38 antibodyBlack Belt Therapeutics Ltd·Filed 2018·Granted Feb 1, 2022·1 cites·17 claims
- 0575US11542338B2CD38 modulating antibodyBlack Belt Therapeutics Ltd·Filed 2018·Granted Jan 3, 2023·1 cites·18 claims
- 0675US2025367286A1Cd38 modulating antibody agentsMERCHIERS PASCAL·Filed 2025·Application pending·0 cites
- 0772US10913801B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2017·Granted Feb 9, 2021·1 cites·16 claims
- 0872US2024092928A1Cd38 modulating antibodyBlack Belt Therapeutics Ltd·Filed 2023·Application pending·0 cites
- 0969US12162949B2CD38 antibodyBlack Belt Therapeutics Ltd·Filed 2022·Granted Dec 10, 2024·0 cites·12 claims
- 1069US8871456B2Probe incorporation mediated by enzymesTING ALICE Y·Filed 2012·Granted Oct 28, 2014·1 cites·19 claims
- 1164US12343394B2CD38 modulating antibody agentsBlack Belt Therapeutics Ltd·Filed 2018·Granted Jul 1, 2025·0 cites·19 claims
- 1263US12304964B2CD38 modulating antibodyBlack Belt Therapeutics Ltd·Filed 2022·Granted May 20, 2025·0 cites·16 claims
- 1363US12161717B2CD38 modulating antibody agentsBlack Belt Therapeutics Ltd·Filed 2018·Granted Dec 10, 2024·0 cites·18 claims
- 1459US12180299B2Multispecific antibody analogs comprising a common light chain, and methods of their preparation and useADIMAB LLC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 1559US11780930B2CD38 modulating antibodyBlack Belt Therapeutics Ltd·Filed 2018·Granted Oct 10, 2023·0 cites·17 claims
- 1655US2023220084A1Antibodies Targeting CLEC12A and Use ThereofDRAGONFLY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1752US2024117054A1Proteins binding nkg2d, cd16 and flt3DRAGONFLY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1852US2024228628A9Antibodies targeting flt3 and use thereofDRAGONFLY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1950US2022025037A1Antibody variable domains targeting dll3, and use thereofDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2047US11498972B2Anti-OX40 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Nov 15, 2022·0 cites·24 claims
- 2145US2017022291A1Multispecific antibody analogs comprising a common light chain, and methods of their preparation and useADIMAB LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hemanta Baruah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →